A possible control strategy against the spread of an infectious disease is the treatment with antimicrobials that are given prophylactically to those who had a contact with an infective person. The treatment continues until recovery or until it becomes obvious that there was no infection in the first place. The model considers susceptible, treated uninfected exposed, treated infected, (untreated) infectious, and recovered individuals. Since treatment lengths have an arbitrary distribution, the model system consists of ordinary differential and integral equations. A sharp threshold condition is established in terms of a basic replacement ratio (disease reproduction number) that separates disease extinction from uniform disease persistence. We use results from dynamical systems persistence theory proving the existence of a global compact attractor along the way. Existence and multiplicity of endemic equilibria are also studied.
Introduction
Antimicrobial drugs can be useful for the control and treatment of infections, in particular when vaccination is not possible or effective, or cannot be done in time. The best known examples are antibiotics that are used against bacterial diseases. Examples of antiviral drugs against influenza are amantadines, which are only effective against influenza A, and neuraminidase inhibitors, which are effective against influenza A and B [2] . If antimicrobial treatment is applied only after an infected individual develops symptoms, we speak about symptomatic treatment. Treatment can also be prophylactic. In this case, the drugs are administered to individuals who have been exposed to the disease by contact with an infective individual. If infection has occurred, the treatment is expected to reduce the duration and severity of infectiousness; if not, the treatment is expected to reduce the susceptibility in case of another exposure.
This study focuses on the effect of prophylactic treatment on the dynamics of an infectious disease. In this paper, we will derive a threshold condition for the treatment to be able to eradicate *Corresponding author. Email: thieme@math.asu.edu; tridane@math.asu.edu; kuang@asu.edu the disease. This threshold will be formulated in terms of a basic replacement ratio (disease reproduction number), R 0 , that gives the number of secondary infections which one average infected individual produces when introduced into an otherwise completely susceptible population. If R 0 ≤ 1, i.e. if an infected individual does not replace itself or does so only marginally, the disease dies out. The threshold condition will be sharp, as we will show for R 0 > 1 that the disease persists uniformly in the host population (Section 4), in the sense that the number of infectives is bounded away from 0 for large times (with the asymptotic bound not depending on the initial conditions). We will also discuss the existence and uniqueness of endemic equilibria (Section 5). In a sequel [10] , we will study whether prophylactic treatment drives the disease towards an endemic equilibrium or rather into undamped oscillations in case that eradication cannot be achieved.
Our model is a simplification of the one studied in [2] . Since we focus on prophylactic treatment, we ignore symptomatic treatment and consequently do not distinguish between symptomatic and asymptomatic infectives. However, we need to distinguish between treated and untreated infected individuals. In order to keep the analysis from becoming too complicated, we make the overly optimistic assumption that treated infected individuals are not infectious. Since prophylactic treatment is used before infection is confirmed, we need to consider a class of uninfected exposed but treated individuals, a novel feature introduced in [2] . Notice that, we use the term 'exposed' with the meaning of having had a contact with an infectious individual whether or not an infection has actually occurred. (In mathematical epidemiology, 'exposed' has been often used with the meaning 'infected, but not yet infectious, i.e. in the latent stage'.) More generally than in [2] , we will consider an arbitrary distribution for how long uninfected exposed individuals are treated (in case that they are treated). In [2] , an exponential distribution is assumed, i.e. treatment is terminated at a fixed rate (which in [2] may depend on chronological age). The other extreme is a treatment of fixed length, a possibility that is also included in our model. The impact of the distribution of stage durations on disease dynamics has been studied for the recovery (immune) period [4, 8, 11] and for a period of isolation (quarantine) [1] . In a sequel to this paper [10] , this impact is investigated for the duration of prophylactic treatment as well, though only in the special case that treatment is fully effective also insofar that treated uninfected individuals are not susceptible (see the preview in Section 6).
The assumption of an arbitrary length distribution for the prophylactic treatment makes the mathematical problem infinite-dimensional. More precisely, the state space of the semiflow induced by the solutions of the model has infinite dimension (Section 3.1). This has technical repercussions for our proof of uniform disease persistence which first establishes uniform weak persistence by an ad hoc contradiction argument (Theorem 4.1) and then uses dynamical systems persistence theory [9; Section A.5] to establish uniform strong persistence (Theorem 4.2). In performing this second step, the infinite dimensionality of the state space forces us to prove the existence of a compact invariant set that attracts all points; actually we prove that there is a compact invariant set that attracts the whole state space (Appendix 2). This paper is dedicated to Hal Smith on the occasion of his 60th birthday in recognition of his outstanding contributions to and biomathematical applications of dynamical systems in general and persistence theory in particular.
Model
For further simplification, we assume that births balance deaths and that nobody dies from the disease. (We mainly do this for mathematical reasons, but it is a defendable assumption for mild infectious diseases in developed countries.) Consequently, the size of the host population remains constant. The proportion of susceptible individuals, at time t, is denoted by S(t), the proportion Downloaded by [Arizona State University] at 14:31 21 September 2012 of uninfected exposed but treated individuals by U(t), the proportion of infective (and untreated) individuals by I (t), the proportion of treated infected individuals by J (t), and the proportion of recovered individuals by R(t),
= S(t) + U(t) + I (t) + J (t) + R(t).
(
Susceptible individuals (S-class) who are exposed (i.e. have a contact with an infective individual) move into the U -class if they are not infected but treated ( Figure 1 ). If they are infected and treated, they move into the J -class. If they are infected and not treated, they move into the I -class. U -individuals (uninfected treated) become susceptible again (move back into the S-class) once treatment is terminated. Infected individuals, whether in the I -class (treated) or in the J -class (untreated), recover into the R-class where they are immune to the disease. R-individuals, upon losing their immunity, return to the S-class. Uninfected exposed but treated individuals (U -class) are assumed to have a susceptibility that is different from that of the susceptible individuals (S-class). Unless the treatment completely suppresses their susceptibility, they can be infected and move either into the J -class of treated infected or the I -class of untreated infected individuals.
For mathematical simplicity, we make the overly optimistic assumption that infected individuals who are treated are not infective. We also assume that the treatment of infected individuals continues until they have recovered from the disease. Ignoring a latency period, we further assume that untreated infected individuals are infectious. Untreated infected individuals recover from the disease at a fixed rate γ 1 , treated infected individuals at a fixed rate γ 2 .
The proportion of uninfected exposed but treated individuals is stratified along their treatment age, a, the time which has passed since their treatment started,
where u(t, ·) is the stage age density of treated uninfected exposed individuals at time t. It is further assumed that the treatment changes the susceptibility of exposed uninfected individuals to secondary infections. We let p denote the probability that a susceptible individuals is actually infected upon the contact with an infective individual and τ the probability that an exposed individual (whether infected or not) is treated. If κ is the per capita contact rate, the incidence is pκI (S + T ) where T (t) is the weighted proportion of uninfected exposed individuals under the effect of treatment, proportion of treated uninfected exposed individuals at time t u(t, ·) treatment age density of treated uninfected exposed individuals I (t)
proportion of infectives at time t J (t)
proportion of treated infected individuals at time t R(t)
proportion of removed individuals at time t
Here, q(a) is the factor by which treatment changes the susceptibility of an uninfected exposed individual of treatment age a when compared with the susceptibility of a typical susceptible individual. Since we consider proportions of susceptible individuals etc., we have implicitly assumed standard (frequency-dependent) incidence. We have the following equations,
The natural per capita death rate μ is also the per capita birth rate, and ρ is the rate at which recovered individuals become susceptible again. In deriving a formula for u(t, a) we must distinguish the cases t < a and t > a. For t > a, u(t, a) describes the uninfected individuals whose treatment started after time 0, namely at time t − a > 0, and so
Here, 1 − p is the probability of having not been infected at exposure. Further per capita recovery rate of (untreated) infectious individuals γ 2 per capita recovery rate of treated infected individuals ρ per capita rate at which a recovered individual looses immunity κ per capita contact rate p infection probability at a contact τ probability that an exposed individual is treated q(a) factor by which treatment reduces the susceptibility of an uninfected exposed individual of treatment age a when compared with a susceptible individual where e −μa is the probability of not having died a natural death in a time span of length a and F(a) is the probability of still being treated at treatment age a. So, G(a) is the probability of still being in the class of treated exposed though uninfected individuals. Finally, π(t, a) is the probability of not having been infected by time t and treatment age a.
For a > t ≥ 0, u(t, a) describes the uninfected exposed and treated individuals whose treatment started before time 0 and had treatment age a − t at time 0,
Here, G(a)/G(a − t) is the conditional probability of still being in the class of treated though uninfected individuals at treatment age a under the proviso of having been in this class at time 0, with treatment age a − t. The class age density u 0 represents the individuals in the treated exposed though uninfected class at time 0.
The probabilities π(t, a) of not having been infected by time t and treatment age a satisfy the partial differential equation (PDE),
with ∂ t and ∂ a denoting the partial derivatives with respect to time t and treatment age a. Integration along characteristic lines ([9; Eqn. (13.4)] e.g.) yields
Here, [r] + = max{r, 0} is the positive part of the real number r. We substitute this formula into Equations (5) and (7),
We assume that F : R + → R is non-negative and monotone decreasing and that D T = ∞ 0 F(a) da, the average time an exposed individual is treated (neglecting natural death) [9; Chapter 12], is finite.D T = ∞ 0 G(a)da is the average duration of treatment for uninfected exposed individuals taking natural death into account.
To put Equations (8) and (9) into another perspective, we assume that F(a) > 0 for all a ≥ 0 and that F is continuously differentiable. Then ζ(a) = −F (a)/F(a) is the rate at which the treatment is terminated a time units after it started. Assume that I , S and u 0 are continuously differentiable as well. By Equations (8) and (9), for t, a ≥ 0,
Here, ∂ t u and ∂ a u denote the partial derivatives of u with respect to t and a, respectively. Integrating this first order PDE with initial and boundary values along characteristics retrieves Equations (9 
In this special case, our model becomes a system of ordinary differential equations in the dependent variables U, I, J, R with the auxiliary variable S.
Well-posedness of the model
In order to solve system (4), (8) , and (9), we rewrite it as a system of differential and integral equations. This is done by substituting Equations (8) and (9) into the equations for T and U in system (4) and performing appropriate changes of variables,
If a > 0 and G(a) = 0, we assume that u 0 (a) = 0 and set
Existence and uniqueness of solutions
In a next step, we integrate the differential equations in Equation (11) using the variations of constants formula and combine them with Equations (12) and (13). This yields a system of integral equations which can be treated very similarly as the integral equation one obtains when solving ordinary differential equations. Since we are interested in non-negative, solutions one applies the contraction mapping theorem to the non-negative cone of an appropriate space of continuous functions. In order to enforce the non-negativity, one replaces S by 
This estimate is needed anyway for the solutions to be biologically meaningful. We first assume that G is continuously differentiable and S(0) > 0. Since G is monotone decreasing, differentiating U in Equation (13),
t)I (t) − κpT (t)I (t) − μU (t).

So, S (t) ≥ −κS + (t)I (t) − μS(t).
This estimate also extends to t = t 1 , a contradiction 
Then, G n is continuously differentiable, monotone decreasing, and 0 ≤ G n (a) G(a) as n → ∞ for a.a. a ≥ 0. Then, we find solutions I n , J n , U n , R n , which converge to the solution I, J, R, U with U n (t)
and b = ∞ as before.
Semiflow
As state space we choose a subset X of L 1 (R + ) × R 3 , endowed with the product topology,
X is a metric space. If we have found a solution U, I, J, T , R of Equations (11)- (13) for given initial data u 0 , I 0 , J 0 , and R 0 , we define u by Equations (8) and (9) and define a map :
Obviously, (0, x 0 ) = x 0 . If F and u 0 are differentiable, I and S are differentiable and u is described by the PDE (10) . In this case, it is easy to see that is a semiflow, i.e.
For the general case, see Appendix 1. 
R 0 is the basic replacement ratio (basic reproduction number of the disease), i.e. the average number of secondary infections produced by one average infected individual that is introduced into an otherwise completely susceptible population. Indeed, 1/(μ + γ 1 ) is the average duration of the infectious period (average sojourn time in the class of untreated infected individuals) with natural death being taken into account. So, κ/(μ + γ 1 ) is the number of contacts made by one average infected individual.
(1 − τ ) is the probability that this infected individual is actual infectious, and p the probability that an exposed susceptible individual contracts the infection. In the following, we use f ∞ = lim sup t→∞ f (t) for a bounded function f : R + → R.
Proof Suppose that the disease does not persist uniformly weakly. Let > 0, which will be chosen as small as needed. Then there exists some solution I (which may depend on ) such that I (0) > 0, but I ∞ < . From the second part of Equation (4),
From the third part of Equation (4),
By Equation (9), since solutions are non-negative,
by a corollary to Fatou's Lemma [9; p. 468]. By the same token, since S(t) ≤ 1,
By the fourth equation in system (4), 
I (t) I (t)
In the following, we use the expected length of remaining treatment at treatment age a (natural death included) [9; Section 12.4],D
THEOREM 4.2 Let sup a≥0D T (a) < ∞ and sup a≥0 G(a + t)/G(a) → 0 as t → ∞. Then the disease is uniformly strongly persistent if
Proof We apply [9; Thorem A.32]. As we have seen in Section 3.2, the solutions of our model system induce a semiflow on the state space X in Equation (14) with
(t, x 0 ) = (u(t, ·), I (t), J (t), R(t)), x
We define ρ : X → R + by ρ(u, I, J, R) = I . In the language of [9; Thorem A.32], Theorem 4.1 implies that the semiflow is uniformly weakly ρ-persistent. In Appendix 2, it is shown that X has a compact attractor: there exists a compact set B in X such that, for any open set V in X with B ⊆ V , there exists some r > 0 such that ([r, ∞] × X) ⊆ V . In particular, the compactness condition (C) of [9; Thorem A.32] is satisfied and it follows that is uniformly strongly ρ-persistent. This translates into uniform strong disease persistence.
We conclude this section by showing that R 0 > 1 is a sharp condition for disease persistence provided that q(a) ≤ 1 for all a ≥ 0. This inequality means that treated uninfected individuals are less susceptible than susceptible individuals. For mathematical completeness, we also present the case that q(a) > 1 for some a ≥ 0. In this case, treatment would increase the susceptibility of exposed but uninfected individuals at least for some period of time. 
Proof By assumption, T (t) ≤ U(t) for all t ≥ 0. By the first equation in system (4),
I ≤ (1 − τ )pκI (S + U) − (γ 1 + μ)I ≤ (γ 1 + μ)I (R 0 (1 − I ) − 1).
Equilibria
An equilibrium of system (4), (8) , and (9) is a time-independent solution of this system. So, it is a solution of the algebraic system
where
Notice that u given by Equation (19) automatically satisfies Equation (9),
, a > t.
There always exists the disease-free equilibrium S = 1, U = I = J = R = 0, u(a) = 0. By definition, an endemic equilibrium of system (4), (8) , and (9) satisfies I > 0 and is described by the system
In order to discuss the existence and uniqueness of endemic equilibria, we first eliminate R. Set Then, S = 1 − U − ξ 1 I − ξ 2 J and, from the first and second parts in Equation (21),
We eliminate J ,
with
Next, we eliminate S,
We divide the first equation by μ + γ 1 and substitute the third equation into the first,
We solve the second equation in system (27) for
We substitute this equation into Equation (28) and reorganize,
Existence of endemic equilibria
The right-hand side of Equation (29) is a continuous function of I , which is negative for I = 1/ξ and, if R 0 > 1, positive for I = 0. By Equations (23) and (22),
. By the intermediate value theorem, the right-hand side has a zero for some I ∈ (0, 1/ξ ). By Equation (28), 0 < 1 − ξI − U = S. So, we have found a meaningful endemic equilibrium in case that R 0 > 1.
Uniqueness and multiplicity of endemic equilibria
We assume that the factor q by which treatment changes the susceptibility of exposed uninfected individuals does not depend on their treatment age. For the scenario considered in this paper, it is realistic to assume that treatment does not increase the susceptibility, q ≤ 1. In this case, (as we will show) there exists at most one endemic equilibrium.
For mathematical completeness, we also study the case q > 1 in which treatment increases the susceptibility of exposed but uninfected individuals. If the mean duration of treatment is short Downloaded by [Arizona State University] at 14:31 21 September 2012 when compared with the mean durations of the infectious, treated infected, and removed periods, there still is at most one endemic equilibrium. If the mean duration of treatment is sufficiently long when compared with these other periods, there may be two endemic equilibria.
The mean duration of treatment (accounting for natural death),D T , is given bỹ
while the mean durations of the infectious, treated infected, and removed periods (also accounting for natural death),D I ,D J , andD R , are given bỹ
The probabilities of surviving the infectious and the treated infected period are given by
THEOREM 5.1 (a) Let q ≤ 1 or, more generally,
Then there is no endemic equilibrium if R 0 ≤ 1 and exactly one endemic equilibrium if
Then there exists some R ∈ (0, 1) with the following property: Proof Let us first consider the case that q is identically zero. By Equation (23), g(I ) = 0 for all I and f (I )/I is a positive constant by Equation (22). This implies that the right hand side of (33) is strictly decreasing. So there is no endemic equilibrium if R 0 ≤ 1 and a unique endemic equilibrium if R 0 > 1. For the rest of the proof, we assume that q is a positive constant. By Equations (23) and (22), f (I ) = g(I )/q for all I . We rewrite Equation (29),
The function g is increasing even if q is not constant. By Equation (23), 
We integrate by parts, using Q(0) = 0 and a Stieltjes integral [9; Corollary B.11],
Since G(a) is monotone decreasing, g(I ) is an increasing function of I and g (I ) ≥ 0.
is a strictly increasing function of x. Since g is increasing, the right-hand side of Equation (33) is strictly decreasing. So there is at most one endemic equilibrium if q ≤ 1. Since we already know that there exists an endemic equilibrium if R 0 > 1, there exists a unique endemic equilibrium if R 0 > 1 and q ≤ 1. If R 0 ≤ 1, the right hand side of (33) is non-positive at I = 0, and so there exists no endemic equilibrium if R 0 ≤ 1 and q ≤ 1, as we can also conclude from Theorem 4.3.
We turn to the case q > 1. We rewrite Equation (33) as
and make a change of variables. By Equation (36),
Notice that ψ(0) = 0. We set y = qκI . From Equation (37) we obtain the following equation for an endemic equilibrium,
In the following, we study the right-hand side of this equation, the function F . Since ψ(0) = 0,
By Equation (38),
Since −G(a) is strictly increasing on some open interval, ψ is strictly decreasing and positive, ψ (y) → 0 as y → ∞. Since ψ is strictly increasing, F is strictly increasing (recall we study the Downloaded by [Arizona State University] at 14:31 21 September 2012
where, by Equation (41),
By Equation (16),
By Equations (24) and (31),
We return to Equation ( 
Discussion and preview
In this paper, we consider thresholds for disease persistence and extinction in a model for infectious diseases where exposed individuals are being treated as a precaution whether or not they have been infected. We allow the length distribution of the treatment of exposed uninfected individuals to be arbitrary, including termination of treatment at a fixed rate (exponential distribution) and treatment of a fixed length (point distribution). The thresholds for disease persistence can be formulated for the basic replacement ratio (basic disease reproduction number), R 0 , the average number of secondary infections produced by one average infected individual that is introduced into an otherwise completely susceptible population. If R 0 > 1, the disease persists and there exists a unique endemic equilibrium. The expression for R 0 is not affected by the distribution of treatment length.
Under the assumption that treatment lowers the susceptibility of exposed but uninfected individuals, there is only this one relevant threshold for R 0 . If R 0 ≤ 1, the disease dies out.
In the improbable case that treatment makes exposed but uninfected individuals more susceptible, there may be two endemic equilibria. If the average length of treatment is sufficiently long compared with the lengths of the infective, untreated infected, and removed periods, there is a second threshold parameter R < 1: there are two endemic equilibria if R < R 0 < 1, one endemic equilibrium if R 0 = R or R 0 ≥ 1, and no endemic equilibrium if R 0 < R . The exact value of the threshold R depends on the length distribution of treatment, but whether or not R < 1 only depends on the average length of treatment. Downloaded by [Arizona State University] at 14:31 21 September 2012
In a sequel to this paper [10] , we study the impact of the length distribution of treatment on the occurrence of undamped oscillations in disease prevalence. In addition to the overly optimistic assumption already made in this paper that treated infected individuals are not infectious, we make the overly optimistic assumption that treated uninfected individuals are not susceptible at all (q(a) = 0 for all a ≥ 0). (In [2; Table A1 ] it has been estimated that the susceptibility of treated uninfected individuals is 0.5 that of susceptible individuals and that the rate of infection by treated wild-type virus is 0.5 that by untreated wild-type virus.) These assumptions and some other simplifications allow us to reduce our system of differential and integral equations to a single integro-differential equation and to apply powerful frequency-domain (Fourier transform) results [6] . Their application, in combination with the persistence result obtained in this paper, provides some clear-cut statements when and when not undamped oscillations can occur. These statements can then serve as educated conjectures for more realistic models, which can only be explored by numerical simulations or other computational tools.
One such statement in [10] is that the disease dynamics tend to an equilibrium when the exposed uninfected individuals are not treated for too long, more precisely when
Here,D T is the mean duration of treatment andD I the mean duration of the infectious period (for untreated infected individuals) with both durations taking natural death into account. Further τ denotes the probability of treatment and p the probability that a contact between a susceptible and an infectious individual results in an infection. Given the difficulty of identifying exposed individuals, it may be a reasonable assumption that τ is considerably smaller than p. In [2; Table A1 ], p (1/c in their symbolism) has been assumed to be 0.5 in the absence of data. [2; Table 1 ] considers τ = 0, 0.01, 0.05 (and various levels of symptomatic prophylaxis, which is not incorporated in our model), while [2; Figure 4 ] covers a range of τ from 0 to 0.4. For the containment of an influenza pandemic, [7] assumes that 80% of all index cases could be ascertained and that these and their entire mixing groups (household, daycare center, playgroup, school) would receive prophylactic treatment. One would assume that exposed uninfected individuals are no longer treated once it becomes reasonably sure that they are uninfected indeed. Ferguson et al. [2] use uses an average length of six days for the infectious period (two days asymptomatic and four days symptomatic) and an average length of treatment of uninfected exposed individuals of three days (1/ξ in [2; Table A1 ]). Longini et al. [7] considers treatment lengths of up to one week, four weeks, six weeks, and eight weeks and report that six weeks are almost as effective as eight weeks but considerably more effective than four weeks in disease prevention. But this is for the containment of a pandemic, and the target unit is not a single exposed individual but the exposed mixing group of an index case. So one would cautiously conjecture that in typical endemic situations the average durations of prophylactic antimicrobial treatment are too short to give rise to undamped oscillations. Our results in [10] do not only put restrictions on the average duration of the treatment, but also on its length distribution. For instance, if treatment is terminated at a fixed rate (leading to an exponential distribution of treatment length), the disease dynamics converge to an (disease-free or endemic) equilibrium even for very large treatment length averages. More generally, if F(a) (the probability of still being treated when treatment started a time units ago) is a convex function of a, the disease dynamics converge towards an equilibrium. The investigation of gamma-distributed treatment lengths suggests that convergence to equilibrium occurs when the standard deviation is sufficiently large compared with the average length. But we could not verify this conjecture for other treatment length distributions.
Conversely, we show in [10] Undamped oscillations can also occur for gamma-distributed treatment lengths where the standard deviation is small compared with the mean, under the same proviso as before.
